Table 2 Medication therapy during the 12 week training program, n = 60
medication | training group (n = 30) | control group (n = 30) | p value |
|---|---|---|---|
statins | 19 (63%) | 15 (50%) | 0.29 |
antiplatelet drugs | 9 (30%) | 7 (23%) | 0.56 |
β-blocker | 15 (50%) | 14 (46%) | 0.79 |
RAAS inhibitor | 20 (66%) | 14 (46%) | 0.12 |
calcium channel blocker | 8 (26%) | 9 (30%) | 0.77 |
antidiabetic drugs | 10 (33%) | 9 (30%) | 0.78 |
diuretics | 12 (40%) | 8 (26%) | 0.27 |